Cogent Biosciences Inc Earnings

The next earnings date for Cogent Biosciences Inc has not yet been scheduled.

Analyst Estimates of Cogent Biosciences Inc Earnings

No Results.

Report Date	Estimated Earnings Per Share
No Results.

What is an Earnings Date

An earnings date is typically considered to be the date that a company publicly announces its earnings. Many companies in the US stock market do earnings announcements once per quarter.

Earnings announcements are typically accompanied by commentary from the company that explains the earnings performance and speaks to future earnings prospects.

Earnings announcements can cause a company’s stock price to change abruptly, so earnings dates are closely monitored by some investors.

Cogent Biosciences Inc Earnings: Historical

Report Date	Before/After Market	Earnings Per Share	Surprise %
11/17/2025	---	$-0.50	4.38%
08/12/2025	---	$-0.53	9.66%
05/05/2025	Before Market	$-0.52	9.05%
02/24/2025	Before Market	$-0.09	84.58%
10/31/2024	Before Market	$-0.64	-13.21%
08/06/2024	Before Market	$-0.59	-5.36%
05/07/2024	Before Market	$-0.62	-19.23%
02/26/2024	Before Market	$-0.63	-12.50%
11/02/2023	Before Market	$-0.64	-28.00%
08/08/2023	Before Market	$-0.59	-9.26%
05/09/2023	Before Market	$-0.54	5.26%
03/14/2023	Before Market	$-0.56	-7.69%
11/14/2022	Before Market	$-0.50	1.96%
08/09/2022	Before Market	$-0.71	-9.23%
05/10/2022	Before Market	$-0.68	-30.77%
03/15/2022	Before Market	$-0.60	-30.43%
11/10/2021	Before Market	$-0.48	-17.07%
08/16/2021	Before Market	$-0.43	-19.44%
05/12/2021	Before Market	$-0.34	17.07%
03/16/2021	Before Market	$-6.06	-1,088.24%
11/09/2020	Before Market	$-0.28	50.00%
08/11/2020	After Market	$-0.96	-14.29%
05/11/2020	After Market	$-0.80	34.96%
03/26/2020	Before Market	$0.28	124.56%
11/12/2019	After Market	$-1.56	-20.00%
08/12/2019	After Market	$-1.36	15.00%
05/13/2019	Before Market	$-1.56	-17.29%
03/28/2019	Before Market	$-1.16	17.73%
11/12/2018	After Market	$-1.36	2.86%
08/13/2018	After Market	$-1.24	10.14%
05/14/2018	Before Market	$-0.66	-83.33%
03/29/2018	After Market	$-0.24	---
11/03/2017	---	$-0.40	---
05/04/2017	---	$-0.58	---

More About Cogent Biosciences Inc

Website

https://www.cogentbio.com

Country

USA

Full Time Employees

205

Cogent Biosciences, Inc., a biotechnology company, focuses on developing precision therapies for genetically defined diseases. Its lead product candidate includes bezuclastinib (CGT9486), a selective tyrosine kinase inhibitor in Phase 3 trial designed to target mutations within the KIT receptor tyrosine kinase, including KIT D816V mutation that drives systemic mastocytosis, as well as other mutations in KIT exon 17, which are found in patients with advanced gastrointestinal stromal tumors. The company also develops CGT4859, a reversible and selective fibroblast growth factor receptor 2 inhibitor in Phase 1 trial for patients with documented FGFR mutations, including advanced cholangiocarcinoma. It has a licensing agreement with Plexxikon Inc. for the research, development, and commercialization of bezuclastinib. Cogent Biosciences, Inc. is headquartered in Waltham, Massachusetts.

“Cogent Biosciences Inc Earnings” Can Refer to the Cogent Biosciences Inc Earnings Date

Some people say “Cogent Biosciences Inc earnings” as a shortform way to refer to the earnings date.

For example, someone might say, “I plan to hold my Cogent Biosciences Inc position through earnings.” That typically means the person is going to hold their position through the upcoming earnings date.

Owning Cogent Biosciences Inc Stock on the Earnings Date

If you own Cogent Biosciences Inc stock (COGT) on the earnings date, then you will be exposed to the potential price volatility that often accompanies earnings announcements.

A company’s earnings typically have a big impact on its stock price, which explains why the stock price for Cogent Biosciences Inc might exhibit major fluctuations on the day of the earnings announcement. The price fluctuations can go in either direction (up or down), representing a larger potential investment risk and reward than many other days of the year.

There is often a big audience of investors involved with trading Cogent Biosciences Inc shares of stock on its earnings day. This means there is typically more trading volume, liquidity, and price volatility on the day earnings are announced.

These features are attractive to some types of active traders who are looking for stocks that exhibit large price movements and substantial volume.

Learning More Cogent Biosciences Inc Earnings

You can contact us any time if you would like to ask questions about Cogent Biosciences Inc earnings or anything else related to the stock market.